Last Posted: Dec 12, 2019
- Tumor mutations are not alone in the plasma
K Naxoreva, Sci Trans Med, December 11, 2019 - DNA Methylation Cancer Biomarkers: Translation to the Clinic.
Locke Warwick J et al. Frontiers in genetics 2019 101150 - Analysis of solid tumor mutation profiles in liquid biopsy.
Balaji Sai A et al. Cancer medicine 2018 7(11) 5439-5447 - TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing.
Savli Hakan et al. Journal of biotechnology 2019 Jul 30087-93 - SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Mijnes Jolein et al. Oncotarget 2019 Nov 10(60) 6494-6508 - Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine.
Kerachian Mohammad Amin et al. Critical reviews in oncology/hematology 2019 Nov 144102827 - The use of cell free DNA in the diagnosis of HCC.
Banini Bubu A et al. Hepatoma research 2019 5 - Are liquid biopsies a surrogate for tissue EGFR testing?
Goldman J W et al. Annals of oncology : official journal of the European Society for Medical Oncology 2018 29(suppl_1) i38-i46 - Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility.
Pantel Klaus et al. Clinical chemistry 2019 65(1) 87-99 - Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management.
Wu Anjui et al. Clinical chemistry 2019 65(1) 100-107
No hay comentarios:
Publicar un comentario